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Summary 
New hair follicles (HF) do not form in adult mammalian skin unless epidermal Wnt signalling is 
activated genetically or within large wounds. To understand the postnatal loss of hair forming ability 
we made small (2mm diameter) circular wounds and monitored HF formation at the wound site. At 
P2 new follicles formed in back skin, but follicle formation was markedly decreased by P21. Neonatal 
tail also formed wound-associated follicles, albeit in smaller numbers. Postnatal loss of HF 
neogenesis did not correlate with wound closure rate but with reduction in Lrig1-positive papillary 
fibroblasts in wounds. Comparative gene expression profiling of back and tail dermis at P1 and dorsal 
fibroblasts at P2 and P50 showed a correlation between loss of HF formation and decreased 
expression of genes associated with proliferation and Wnt/β-catenin activity. Between P2 and P50 
fibroblast density declined throughout the dermis and clones of fibroblasts became more dispersed. 
This correlated with a decline in fibroblasts expressing a TOPGFP reporter of Wnt activation. 
Surprisingly, between P2 and P50 there was no difference in fibroblast proliferation at the wound 
site but Wnt signalling was highly upregulated in healing dermis of P21 compared to P2 mice. 
Postnatal β-catenin ablation in fibroblasts promoted HF regeneration in neonatal and adult mouse 
wounds while β-catenin activation reduced HF regeneration in neonatal wounds. Our data support a 
model whereby postnatal loss of hair forming ability in wounds reflects elevated dermal Wnt/β-
catenin activation in the wound bed, increasing the abundance of fibroblasts that are unable to 
induce HF formation.  
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Introduction 
Mammalian skin comprises two layers: the epidermis and dermis. The epidermis is made up of the 
interfollicular epidermis (IFE), the hair follicles (HF), sweat glands, and sebaceous glands and is 
maintained through the activity of distinct stem cell subpopulations (Watt, 2014). The underlying 
connective tissue, the dermis, is comprised of distinct layers. The papillary (upper) dermis is the 
closest dermal layer to the epidermis and contains thin collagen fibers and a high density of 
fibroblasts. Below that lies the reticular (or lower) dermis, and beneath that lies the dermal white 
adipocyte (DWAT) layer, also known as the hypodermis (Driskell et al., 2014; Sorrell and Caplan, 
2004). In addition, there are condensations of fibroblasts, called the dermal papilla (DP), at the base 
of the HFs, fibroblasts that ensheath the HF (dermal sheath (DS) cells) and smooth muscle cells in the 
arrector pili muscle (APM) attached to the HF (Driskell et al., 2011a; Sennett and Rendl, 2012). The 
epidermis and dermis form through highly coordinated epithelial-mesenchymal interactions during 
development (Driskell et al., 2011a; Fuchs and Horsley, 2008; Millar, 2002; Yang and Cotsarelis, 
2010).   
Skin fibroblasts from different anatomic sites have distinct and characteristic gene expression 
patterns (Rinn et al., 2006). The differentially expressed genes are not only involved in defining cell 
positional identity, but also associated with extracellular matrix (ECM) synthesis, lipid metabolism, 
proliferation, cell migration and fate determination (Chang et al., 2002). Positional differences in 
wound healing and skin regeneration ability have been reported, such that oral mucosa wounds heal 
faster with minimal scaring compared to cutaneous wounds (Chen et al., 2010). 
At embryonic day 12.5 (E12.5) of mouse development dermal fibroblasts in back skin are capable of 
forming all the postnatal dermal compartments (Driskell et al., 2013). However, at E16.5 lineage 
restriction occurs, such that fibroblasts that are expressing Lrig1, Blimp1 or CD26 at that time point 
give rise to papillary dermis, including APM, DS and DP, while Dlk1 expressing fibroblasts give rise to 
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 the reticular dermis and DWAT (Driskell et al., 2013). The papillary lineage is required for new HF 
formation in skin reconstitution assays, while the lower lineage gives rise to the fibroblasts that 
mediate the initial phase of wound repair. 
HF formation is normally restricted to embryonic development (Schmidt-Ullrich and Paus, 2005). 
However, new HF can be induced in a range of adult mammals, including human, in the context of 
wound repair (Breedis, 1954; Kligman, 1959). In adult mice, new HF form in the center of very large 
(1cm2) wounds as a result of epidermal Wnt signalling (Gay et al., 2013; Ito et al., 2007; Myung et al., 
2013). Genetic activation of adult epidermal Wnt signalling via β-catenin can induce ectopic HF 
formation in the absence of wounding (Lo Celso et al., 2004; Silva-Vargas et al., 2005) and this 
correlates with expansion of the papillary dermal lineage (Driskell et al., 2013). Although new 
follicles do not normally form in small (≤8mm) circular full-thickness wounds in adult mouse back 
skin, they can be induced if the number of papillary fibroblasts is expanded in response to epidermal 
Wnt signalling prior to wounding (Driskell et al., 2013). 
The previous studies relating new HF formation to wound healing and the role of different fibroblast 
subpopulations led us to investigate why the ability to form new HF is lost in postnatal life.  To do 
this we have measured the time in postnatal life when HF formation no longer occurs in wounds and 
characterised the associated dermal changes. Our observations lead to the conclusion that loss of 
hair forming ability in adult wounds reflects increased recruitment of lower lineage fibroblasts at the 
expense of papillary fibroblasts, and is promoted by Wnt/β-catenin signalling in the wound dermis.  
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 Material and Methods 
Transgenic mice  
All animal experiments were subject to local ethical approval and performed under the terms of a 
UK government Home Office license. All mice were outbred on C57Bl6/CBA background and male 
and female mice were used in experiments that included the PDGFRaCreERt2 (Rivers et al., 2008), 
Lrig1CreERt2-IRES-GFP (Page et al., 2013), Dlk1CreERt2 (Driskell et al., 2013), ROSAfl-stopfl-
tdTomato (Jackson Laboratories, 007905), CAGCATeGFP (Kawamoto et al., 2000), TopH2BeGFP 
(Ferrer-Vaquer et al., 2010), PDGFRaH2BeGFP (Hamilton et al., 2003), beta-catenin floxed (Huelsken 
et al., 2001), and Catnbexon3 mice (Harada et al., 1999). To perform lineage tracing or modulate β-
catenin activity in fibroblasts PDGFRaCreERt2 were bred to the appropriate floxed mice and treated 
with tamoxifen.  
 
Wounding experiments  
Analgesic EMLA cream 5% (AstraZeneca) was applied to the skin for 10min before mice were 
anaesthetized using Isoflurane (Cp-pharma).  A 2mm diameter punch biopsy (Stiefel) was used to 
make a full thickness wound in the central back skin or tail base at indicated time points.  If 
necessary, the hair on the back was clipped prior to wounding. When neonatal mice (P2-P10) were 
wounded, all litter pups were wounded and housed with their mother until weaning age.  Wound 
closure was quantitated by comparing digital wound bed photos on the isolation day.  
 
Clonal analysis 
CAGCATeGFP mice were crossed with PDGFRaCreERt2 mice. Cre was induced at E12.5 by injecting 
pregnant females with 25g Tamoxifen/g, which we have previously shown labels fewer than 1% of 
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 all skin fibroblasts (Driskell et al., 2013). At E14.5 GFP labelled cells were analysed in n= 3 horizontal 
whole mounts per embryo (n=3 embryos per time point) by confocal microscopy. All labelled cells 
within a 260±50m radius (Driskell et al., 2013) were scored as being clonally related. For postnatal 
clonal analysis neonatal mice (P0) were injected with 12.5µg Tamoxifen/g, labelling 1-2 cells per HF 
region, i.e. the area of dermis between adjacent HF, and analysed at different time points. All clones 
in n=3 whole mounts per mouse (n=3 mice per time point) were analysed.  
Immunostaining  
Immunostaining was performed on 60µm cryosections stained as horizontal whole mounts as 
previously described (Driskell et al., 2013; Driskell et al., 2011b).  Briefly, skin was fixed in 4% PFA for 
15-30min, washed with PBS and embedded in OCT.  60µm cut sections were place into PBS to 
dissolve the OCT. Sections were stained in 300-500µl PB-buffer (PBS containing 0.5% skimmed milk, 
0.25% cold water fish skin gelatin, 0.5% TritonX-100). Whole mounts were labelled with primary 
antibody (overnight, 4°C), washed in PBS for 1h (room temperature), and with secondary antibodies 
containing DAPI (1g/ml diluted 1:2000) for 2h (room temperature) (Table S4). Whole mounts were 
mounted on coverslips with glycerol and imaged with a Nikon A1 Upright Confocal using NIS 
Elements Software package to stitch multiple 1024x1024 images. Since wounds were only 2mm 
diameter we could capture the entire width of each wound in one whole mount (60µm section) and 
by analysing multiple whole mounts from each wound we could readily quantitate all the HF per 
wound. 
 
Flow cytometry  
Fibroblasts were isolated as previously described (Jensen et al., 2010). Briefly, back skin was isolated 
and incubated in dispase-trypsin solution at 37°C, 1h. Dermis was separated from the epidermis, 
transferred to 0.25% Collagenase in FAD medium, minced and incubated at 37°C, 1h.  The digest was 
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 passed through a 70µm filter before centrifugation. For cell sorting, cells were washed with PBS and 
sorted using a BD-FACS-Aria-Fusion. For FACS-analysis, fibroblasts were incubated 1h with antibodies 
(Table S4), washed with PBS and analysed with a FACS-Canto-TMII. All data analysis was carried out 
with FlowJo9.8.5. 
 
Microarrays 
Neonatal (P2) and P50 back skin PDGFRaH2BeGFP fibroblasts microarrays were published previously 
(GSE-32966) (Collins et al., 2011). To generate back and tail dermis microarray from P1 mouse 
(C57Bl6/CBA F1), tail skin was incubated in 5mM EDTA/PBS solution at 37°C, 1h, whereas back skin 
was incubated in dispase-trypsin solution at 37°C, 1h. Tail and back skin dermis were separated from 
the epidermis with forceps, washed once in PBS and digested as described above. Single-cell 
suspensions were washed 3x in PBS, before cells were lysed in Trizol (Invitrogen) and RNA was 
purified using Qiagen RNeasy columns. RNA was extracted from triplicate mice. cDNA was amplified 
from purified RNA and hybridized to Affymetrix MG430.2A arrays by the Cancer Research UK 
Patterson Institute Affymetrix Genechip Microarray Service.  Array images were produced by the 
Affymetrix PICR 3000 scanner and analysed as Cell files using Genespring-13X (Agilent Technologies). 
RMA normalization was used and the bottom twentieth-percentile of genes (i.e., the 20% of genes 
with the lowest expression levels) were excluded from subsequent analysis.   
Quantitation and statistical analysis 
Statistical analysis was performed with GraphPad Prism6 software. Unless stated otherwise, 
statistical significance was determined by unpaired t-test for biological effects with an assumed 
normal distribution. For unbiased cell identification with DAPI, Ki67, TOPH2BeGFP or 
PDGFRaH2BeGFP labelling nuclear staining was quantified using the spot detector plugin of ICY 
software (Version1.6.0.0). To quantify Lrig1 and Sca1 expressing cells in the wound bed, mean 
fluorescence was determined with ICY software (Version1.6.0.0) and normalized to background. 
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 To quantitate new HF at least 8x60µm sections per wound covering the entire wound bed were 
stained with the indicated antibodies and HF number per wound bed was counted.  
Total and dermal layer fibroblast density was quantitated in PDGFRaH2BeGFP whole mount sections 
by counting EGFP+ cells in the dermis between adjacent HF (30 inter-HF regions scored per biological 
replicate) and in the wound bed (3 wound beds per biological replicate) at indicated time points. 
PCR analysis 
Flow cytometry was used to sort tdtomato+ and tdtomato- cells. DNA was prepared from sorted 
cells and whole mount sections with DNA-lysis buffer (100mM Tris-Cl pH 8.8, 50mM NaCl, 5mM 
EDTA pH 8.0, 0.2% SDS, 0.2mg/ml ProteinaseK), precipitated with Isopropanol, washed with 70% 
ethanol and resuspended in TE-buffer (10mM Tris-Cl, 1mM EDTA, pH 8.0).  
For PCR analysis, PCR Mastermix (Promega, M7502) and following primer pairs (Table S5) were used. 
PCR was performed on a C1000 Touch Thermal Cycler (BioRad) with following cycle conditions: 94°C 
for 1min followed by 32 cycles of 94°C for 30s, 55°C for 1min and 72°C for 1min. PCR products were 
loaded on a 3% agarose gel and imaged with a GelDoc-XR+ using ImageLab software (BioRad, 
Version5.2).  
Calculation for cell division rate  
We measured the body length (from between the scapulae to tail base), width (at widest point) and 
dermis depth (from back skin sections) of P2 and P50 mice (n=3 biological replicates) (Table S3). We 
used these measurements to obtain the approximate body size, represented as a cylinder (Fig.4A). 
The total mouse volume can be approximated by calculating the cylinder volume, V, 
𝑉 = 𝜋𝑟2ℎ      (1) 
where the radius, r, represents half of the body width and h the animal height .The dermis volume, 
dv, corresponds to the difference between the total volume and the inner volume when the radius is 
the animal total radius minus the dermis depth, dd. 
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 𝑑𝑣 = 𝜋𝑟2ℎ − 𝜋(𝑟 − 𝑑𝑑)2ℎ     (2) 
Let N be the number of fibroblasts in P50 occupying dvP50, N0 the number of fibroblasts in P2 
occupying dvP2 and n the predicted number of cell divisions. If we assume exponential cellular 
growth then 
𝑁 = 𝑁02
𝑛      (3) 
𝑛 =  log2
𝑁
𝑁0
      (4) 
The total number of fibroblast at a certain developmental stage can be approximated by multiplying 
the dermis volume dv by the fibroblast density, ρ. From here we expect 
𝑛 =  log2
𝑑𝑣𝑃50×𝜌𝑃50
𝑑𝑣𝑃2×𝜌𝑃2
      (5) 
𝑛 = 1.3128      (6) 
Based on the result we estimate that dermal fibroblasts undergo one cell division between P2 and 
P50. 
 
 
Results  
HF formation in wounds decreases with age and is location dependent 
To explore HF regeneration capacity, we made 2mm full thickness circular wounds on mouse back 
and tail skin of different ages. Seven days after wounding (PW7) new HF had formed in the wound 
bed of P2 back skin, with an average of 5 new HF per wound bed section (Fig.1A,B). When P2 skin 
was wounded, all HF developmental stages (Müller-Röver et al., 2001) were present at PW7 (Fig.1C), 
indicating that new HF formation was not a synchronized process. The more developed HF (Stage4-
6) tended to be at the wound edges, whereas placodes (Stage1) and Stage2-3 HF were most 
abundant in the wound bed centre. The number of new HFs per wound did not change between 
PW7 and PW14 (data not shown), pointing to a limited, time dependent window for HF regeneration 
during wound healing. New HF formation strongly declined with age and after P21 only 0.8 new HF 
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 per wound bed section formed. The decline was not correlated with hair cycle (HC), since it occurred 
during the growth (anagen) phase of HF morphogenesis (P6, P10), the first postnatal telogen (resting 
phase; P21) and the second HC (P28-P50) (Fig.1A,B).  
P2 tails were too small to wound. However, when P10 tail was wounded new HFs were detected in 
the wounds, albeit in lower numbers (Fig.1D, Table S1) than in P10 back skin. This indicates that 
wound induced HF regeneration potential is not restricted to one particular anatomical site. Tail HF 
formation also appeared to decline with age (Table S1). There was no correlation between wound 
area at PW7 and HF regeneration capacity, either in tail or back skin (Fig.1E-H). Back skin wound 
sizes at PW7 were significantly smaller when mice were wounded in telogen (P21, P50) than anagen 
(P2-10, P28, P36), whereas in tail skin wound size did not change with age (Fig.1F,H). Wound closure 
rates were similar in neonatal and adult wounds (Fig1.I).  
To establish the relative contributions of different fibroblast lineages to new HF formation, we 
labelled Lrig1+ or Dlk1+ cells via CreER-mediated recombination with tdtomato at P0, wounded back 
skin at P2 and analysed new HF formation at P9 (Fig.1J,K). Cells of both the papillary (Lrig1+) and 
reticular (Dlk1+) lineages were present in the wound bed (Fig.1K). The papillary fibroblast lineage 
was associated with the DS and DP of new HFs (8 wound bed sections analysed per mouse; n=4 
mice) while the reticular lineage only contributed to the inter-HF dermis (8 wound bed sections 
analysed per mouse; n=3 mice) (Fig.1K,L). 
We conclude that neonatal skin of different anatomical sites is able to generate HF at the site of 
small, full thickness wounds and that papillary fibroblasts contribute to the new HF, DS and DP, as 
reported previously (Driskell et al., 2013). HF neogenesis is more pronounced in back than tail skin, 
which might be due to differences in HF density of unwounded skin, and declines with age. HF 
formation is not dependent on the HF stage at which the wound is made and does not correlate with 
wound area at PW7.  
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Changes in fibroblast gene expression with dermal maturation and location  
To uncover potential explanations for the differences in HF formation at different ages and body 
sites, we performed gene expression profiling of neonatal (P1) back and tail dermis (Table S2) and 
compared the results with a published dataset of back skin dermal fibroblasts isolated from neonatal 
(P2) and adult (P50) mice (Collins et al., 2011). We found 705 entities that were differentially 
expressed (≥2-fold) between neonatal back and tail dermis, and 5405 entities that were differentially 
expressed in neonatal and adult back skin fibroblasts (Fig.2A). Only 238 entities overlapped between 
the two datasets, reflecting genes that changed with both time and location.Therefore the majority 
of differences in gene expression is between neonatal and adult dermis rather than between 
neonatal dermis in different anatomical locations.   
Gene ontology (GO) analysis of entities differentially represented between neonatal tail and back 
dermis included the GO terms ‘connective tissue’ and ‘appendage development’, which were more 
highly represented in the tail. ‘Fat metabolism processes’ was more highly represented in back 
dermis, consistent with the lack of DWAT in tail skin.   
GO terms for entities that changed in back skin between P2 and P50 included ‘cell division’, ‘cell 
cycle’, and ‘DNA replication’, all of which were significantly down regulated during postnatal skin 
maturation. In contrast, there was a higher representation of entities associated with the immune 
response, angiogenesis, ECM and ‘wound healing response’ in adult back fibroblasts. Additionally, 
many Wnt pathway components were down regulated with age, whereas there was little differential 
expression of Wnt pathway genes between neonatal back and tail dermis (Fig.2B).     
Taken together, the microarray comparisons of RNA isolated from the dermis at different times and 
locations revealed that the positional identity of fibroblasts (back versus tail) affected only a small 
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 number of genes while postnatal dermal maturation triggered changes in multiple genes, including 
downregulation of genes associated with cell proliferation and Wnt signalling.  
 
Postnatal dermal expansion occurs with minimal fibroblast proliferation 
To evaluate changes in postnatal dermis that correlate with loss of HF forming ability, we labelled 
the dermis of PDGFRaH2BeGFP mice for markers that distinguish different fibroblast subpopulations 
at P2 (Driskell et al., 2013) (Fig.3A,B). Quantitation of total dermal fibroblasts, based on expression 
of nuclear EGFP, showed a striking reduction in fibroblast density between P2 and P10, with further 
reductions at P21 and P50 (Fig.3C). In contrast, between P2 and P50 the area between adjacent HF 
increased markedly, reflecting dermal expansion (Fig.3C). When we scored cell density separately in 
the papillary (Pap), reticular (Ret) and DWAT layers (Fig.3D), we found that papillary dermis had the 
highest cell density at P2 and showed a marked decrease at P21. However, between P21 and P50 
papillary and reticular cell density both decreased. In contrast DWAT cell density marginally 
increased with age and at P50 the density in all three dermal layers was similar (Fig.3A,D). During 
skin maturation there were also major changes in expression of the P2 markers of papillary (CD26+, 
Lrig1+) and reticular/DWAT (Dlk1+/-, Sca1+) dermis as previously reported (Driskell et al., 2013). 
CD26 and Sca1 expression extended throughout the dermis with age, whereas Lrig1 and Dlk1 were 
strongly down regulated (Fig.3B).   
To investigate whether the dermal changes correlated with fibroblast proliferation and apoptosis, 
we stained PDGFRaH2BeGFP back skin whole mounts for Ki67 and cCasp3 (Fig.3E-H). We observed a 
strong reduction in Ki67+ fibroblasts between P2 and P10 (Fig.3E,F) and proliferation remained low 
with increasing age. Very few cCasp3+ fibroblasts were detected at any age (Fig.3G,H), while 
apoptosis in the epidermis was HC dependent, as reported previously (Lindner et al., 1997).   
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 We conclude that during dermal maturation the area between HF increases, while fibroblast density 
decreases. The most pronounced decrease in cell density is in the papillary layer, coinciding with the 
loss of HF neogenesis in wounds. The decrease in dermal cell density does not correlate with 
increased apoptosis and after P2 there is very little fibroblast proliferation, consistent with the 
microarray analysis (Fig.2A).  
 
Clonal analysis of fibroblasts during dermal maturation   
To gain more insights into the changes in fibroblast number and distribution during dermal 
maturation we first used our experimental measurements (Fig.3C; Table S3) to model the number of 
cell divisions between P2 and P50 (Fig.4A). By calculating mouse body size at each stage and 
modelling the body as a cylinder we calculated that dermal volume increases 13-fold from 0.18cm3 
(P2 mouse) to 2.32cm3 (average between P50 male and female mice). Combining this with the 
fibroblast density measurements (Fig.3C) we predicted that on average only 1.3 cell divisions occur 
in PDGFRa+ fibroblasts between P2 and P50 (Fig.4A). This is consistent with the low number of 
proliferating cells observed experimentally (Fig.3E,F). From here we could further predict that 
individual fibroblasts labelled at E12.5 would initially form clones of increasing cell number, but after 
P2 clone size would seem to decrease as clonally related cells became distributed over an increasing 
area of dermis.   
To test our hypothesis we performed clonal analysis, defining the maximum diameter occupied by 
clonally related cells as 260±50m, as described previously (Driskell et al., 2013). Fibroblasts in bi-
transgenic PDGFRaCreERt2xCAGCATeGFP mice were labelled with a low tamoxifen dose, which 
resulted in 1-2 PDGFRa+ cells being labelled in the dermis between adjacent HF (inter-HF dermal 
area) (Fig.4B-D). When fibroblasts were labelled at E12.5 they gave rise to clones of 4-8 cells 
spanning the papillary, reticular and DWAT at P2 (Fig.4E,F). Thereafter, the number of cells per clone 
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 decreased in the papillary and reticular dermis and DWAT, but not in the DP, consistent with DP cells 
forming a condensate (Kaushal et al., 2015; Tobin et al., 2003) (Fig.4F). When clonal labelling was 
performed in bi-transgenic mice at P0 (Fig.4D,G), there was no subsequent increase in EGFP-positive 
cells (Fig.4H), consistent with the very low proliferation rate in postnatal skin (Collins et al., 2011; 
Fig.3F). 
We conclude that, consistent with the postnatal increase in dermal volume occurring with very little 
fibroblast proliferation, clonally related cells become progressively separated from one another.  
 
Postnatal dermal maturation coincides with a reduction in dermal -catenin signalling 
In addition to predicting a reduction in fibroblast proliferation during dermal maturation, the 
microarray comparison suggested a significant decrease in Wnt/-catenin signalling. As a read out of 
dermal Wnt signalling we examined the TOPGFP reporter mouse, in which H2BeGFP is expressed 
under control of multiple Lef1/TCF binding sites (Ferrer-Vaquer et al., 2010) (Fig.5). As previously 
reported, at E12.5 Wnt/-catenin signalling is highly active in most fibroblasts (Chen et al., 2012; 
data not shown). TOPGFP+ fibroblasts were abundant at P2, but declined significantly by P21 (Fig.5A-
C). At P2 the number of cells with detectible nuclear TOPGFP, as evaluated by flow cytometery 
(Fig.5D,E) was 17.1% within the papillary (CD26+, Sca1-) population, compared to 7.2% in the 
reticular (Dlk1+, Sca1-) population and 11.8% in fibroblasts with adipogenic potential (8.3% 
Dlk1+Sca1+; 3.5% Dlk1-Sca1+; Driskell et al., 2013; Festa et al., 2011). This was confirmed by 
immunofluorescence staining, since at P2 the upper dermis (enriched for papillary Lrig1+/CD26+ 
fibroblasts) contained more TOPGFP+ cells compared to the lower dermis (Dlk1+, Sca1+) (Fig.5A).  
In line with the microarray analysis, Wnt target genes such as Lef1, DKK1 and CyclinD1 were highly 
expressed in the upper dermis at P2 (Fig.5B). While most TOPGFP+ cells in the upper dermis showed 
high nuclear Lef1 levels, in the lower dermis TCF4 was nuclear in cells that were TOPGFP+. In 
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 contrast, nuclear TCF1 was mainly confined to the papillary fibroblast lineage. These observations 
are consistent with gene expression profiles of neonatal fibroblasts, showing that papillary 
fibroblasts have an active Wnt signalling signature, but also highlights that Wnt signalling can 
simultaneously occur in the lower dermis (Driskell et al., 2013; Mastrogiannaki et al., 2016).   
In adult skin there were fewer TOPGFP+ cells throughout the dermis, with adipocytes and APM cells 
showing the highest TOPGFP signal (Fig.5A-C). The decrease in dermal TOPGFP activity was 
associated with a decrease in expression of all TCFs as well as all analysed Wnt target genes (Fig.5B).  
We conclude that postnatal dermal maturation is associated with reduction in Wnt/-catenin 
signalling. Additionally there is differential signalling activity in different fibroblast subpopulations. 
 
Wound induced dermal β-catenin activation in fibroblasts increases with age  
To examine whether the age-associated fibroblast density changes and Wnt/-catenin signalling in 
unwounded skin were mirrored by changes during wound-healing, we investigated -catenin activity 
in wound beds of neonatal and adult TOPGFP mice at PW5, PW7 and PW10. Surprisingly, there was 
strong dermal Wnt/-catenin activation in adult P21 and P50 wound beds, whereas neonatal P2 
wound beds had fewer TOPGFP+ cells at all time points (Fig.6A,B). In contrast the epidermis showed 
similar TOPGFP activation in the wound bed regardless of age at all time points, except for local 
upregulation in the placodes of new HF (Fig.6A).  
During embryogenesis the Wnt signalling inhibitor DKK1 is highly expressed by dermal fibroblasts, 
creating a permissive environment for HF formation by locally suppressing Wnt/-catenin signalling 
(Andl et al., 2002; Sick et al., 2006). P2 wound beds had strong DKK1 expression in the upper dermis, 
especially surrounding the developing HF (Fig.6F). DKK1 expression was strongly reduced in adult 
wound beds (Fig.6F), correlating with the increased number of TOPGFP+ cells (Fig.6A,B).  
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 Although the total cell density in wounds did not change significantly with age (Fig.6C,I), the number 
of cells expressing papillary (Lrig1) and reticular (Sca1) markers changed as a function of the age on 
wounding and the number of days post wounding (Fig.6D,E; Driskell et al., 2013).  In P50 mice more 
Sca1+ cells were present in the wound bed 7 days after wounding than in P2 mice, while in P2 
wounds Lrig1+ cells predominated at PW7, particularly close to the basement membrane when new 
HF form (Fig.6A,D,E). In adult wound beds the number of Lrig1 expressing cells increased at PW10 
when wound induced HF neogenesis is not observed (Fig.6D). Similarly, there were more Itga8+ cells 
(a previously described marker of papillary fibroblasts, DP and APM cells in P2 skin; Driskell et al., 
2013) in neonatal compared to adult wound beds at PW7 (Fig.6G). In contrast, adult wounds 
contained a higher proportion of cells that expressed α-smooth-muscle-actin (αsma) at PW7 
(Fig.6H), which we have previously shown, by lineage tracing, derive from the lower dermal lineage 
(Driskell et al., 2013).  
Following P2 wounding there were significantly more proliferating (Ki67+) cells in PW7 wound beds 
than at P4 (Fig.6J). However, there was no significant difference in proliferation in the wound beds 
of mice wounded at P4 and P50, even though HF neogenesis declined during that period (Fig.1B).  
Fibroblast density within neonatal and adult wound beds did not differ significantly at PW7 (Fig.6I).  
We conclude that the loss of HF forming ability correlates with an increase in dermal Wnt/-catenin 
signalling, a decrease in the proportion of cells expressing papillary markers and an increase in 
αsma+ cells in the wound bed at PW7, when new HF are able to form. However, wound beds that 
differ in their ability to support HF regeneration do not differ in fibroblast proliferation and density.  
 
Promotion of HF formation in adult wounds by inhibition of Wnt/-catenin signalling 
To determine whether altering dermal Wnt/-catenin signalling would affect HF formation in the 
wound bed, we specifically deleted or activated -catenin in fibroblasts by crossing Ctnnb1flox/flox or 
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 Ctnnb1+/flox(ex3)  with PDGFRaCreERt2xtdtomato mice and applying tamoxifen after birth (P0 and P3) 
(Mastrogiannaki et al., 2016). Both deletion and activation of -catenin resulted in mice that were 
viable but smaller, with a shorter tail than controls (data not shown), effects that probably reflect 
PDGFRaCre activity in tissues such as CNS, bone marrow and developing bone (Betsholtz, 1995). 
Deletion or activation of -catenin did not alter fibroblast density in the papillary and reticular 
layers, nor did it affect expression of papillary and reticular markers in unwounded neonatal and 
adult dermis (Fig.7A-D). There was no effect on APM number or size (data not shown). However, 
whereas at P10 the DWAT was normal, by P57 dermal -catenin stabilization led to a reduction in 
adipocytes and accumulation of scattered fibrotic patches, resulting in an increased DWAT cell 
density and total dermal thickness as previously reported (Mastrogiannaki et al., 2016; Hamburg-
Shields et al., 2015; Hamburg et al., 2012; Fig.7A-E). In contrast, in -catenin deleted mice dermal 
thickness was slightly reduced (Fig.7E).   
To confirm that dermal -catenin modulation had indeed been achieved, we examined TOPGFP 
activity (Fig.8). As expected, -catenin deletion highly reduced Wnt-reporter activity in adult P21 
wound beds (Fig.8A,B), where Wnt/-catenin signalling is high in control mice (Fig.6A,B). Conversely, 
-catenin stabilization increased the number of TOPGFP+ cells in neonatal P8 wounds (Fig.8D,E), 
where Wnt/-catenin signalling is low in controls (Fig.6A,B). In addition, we sorted tdtomato+ cells 
or used whole mount tissue for PCR analysis, confirming efficient deletion of the floxed exons in 
both Ctnnb1flox/flox and Ctnnb1+/flox(ex3) cells (Fig.8C,F); this is comparable to other skin studies (see 
Enshell-Seijffers et al. 2010a). 
Next we wounded the skin at P4 (the earliest possible time point after β-catenin modulation) or P50 
(adult) and analysed the wound bed at PW7 (Fig.9A). In P4 wounds, dermal -catenin activation led 
to an increase in Sca1+ cells in the wound bed, whereas more Lrig1+ cells were present after dermal 
-catenin deletion at PW7 (Fig.9B,C). Although proliferation (Ki67+) in adult wound beds was 
significantly decreased in β-catenin deleted and increased in β-catenin activated dermis (Fig.9D; 
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 Beyer et al., 2012; Chen et al., 2012), dermal cell density was not significantly affect at PW7 (Fig. 9E). 
In addition wound size was slightly increased in P50 β-catenin activated mice (Fig.9F) and, as 
previously shown, β-catenin modulation did not affect wound closure (Cheon et al., 2006). 
Intriguingly, HF formation in the wound bed was significantly increased (1.52-fold) on dermal 
deletion of -catenin (Fig.9G,H), whereas -catenin stabilization inhibited HF formation (0.72-fold) in 
P4 wounds (Fig.9I,J). We occasionally observed enlarged HF in the wound bed on -catenin 
stabilization (arrow in Fig.9I), as has been reported when dermal -catenin is stabilized during 
embryonic development (Chen et al., 2012). When -catenin deleted mice were wounded at P50, HF 
regeneration increased 3.27-fold (Fig.9H). In contrast -catenin stabilization in fibroblasts did not 
affect HF regeneration at P21 or P50 (Fig.9I,J).  
We conclude that, consistent with the observed reduction in dermal Wnt signalling with age (Fig.5), 
-catenin is not essential for fibroblasts to contribute to dermal maturation. Wnt/-catenin 
signalling inhibition in fibroblasts promotes HF regeneration during wound healing, which correlates 
with a reduction in the number of cells expressing markers of reticular fibroblasts and increase in 
cells expressing papillary fibroblast markers.   
 
Discussion 
It has previously been reported that new HF formation ceases after E19.5 of mouse development 
(Colwell et al., 2006; Martin et al., 2003; Shaw and Martin, 2009). Here we demonstrate that 
neonatal mouse skin is capable of forming new HF during wound healing and that this ability is 
largely lost within the first 3 weeks after birth. The loss of HF ability correlates with a decline in 
papillary fibroblast density and dermal -catenin signalling in undamaged skin. However, on 
wounding dermal -catenin activity is upregulated to a greater extent in older than neonatal wounds 
and this is linked to a greater proportion of fibroblasts expressing reticular markers, consistent with 
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 previous lineage tracing studies that showed these cells lack HF inducing ability (Driskell et al., 2013). 
By ablating -catenin in PDGFRa+ cells we were able to partially restore HF formation in wounded 
older skin. Our results are consistent with an earlier report showing that during wound repair -
catenin signalling is highly upregulated in the fibroblasts of adult mice (Cheon et al., 2006). It is 
notable that the loss of hair forming capacity in adult skin does not reflect a change in the ability of 
the epidermis to form new follicles, since ectopic HF can be induced in unwounded and wounded 
skin by epidermal -catenin activation (Deschene et al., 2014; Lo Celso et al., 2004; Ito et al., 2007; 
Silva-Vargas et al., 2005). 
It is interesting to speculate that one reason why P2 skin can regenerate HF while P21 skin cannot is 
that from P5 onwards many of the papillary fibroblasts are recruited to form the APM and this may 
render them unable to contribute to restoring the papillary dermis (Driskell et al., 2013). However, 
altered dermal -catenin activity did not affect the number or size of individual APM. There is no 
evidence that existing DP cells contribute significantly to wound repair in adult skin (Johnston et al., 
2013; Kaushal et al., 2015). Nevertheless, new DP can be induced upon epidermal -catenin 
activation (Silva-Vargas et al., 2005). Neonatal tail skin was able to form new HF in wounds and this 
is consistent with the lack of differential Wnt gene expression between tail and back (Fig.2). We 
speculate that the lower number of wound-associated HF in neonatal tail skin could be due to the 
lower density of HF in unwounded tail or to the lack of papillary progenitors of the APM.  
The importance of Wnt signalling in skin fibroblasts has been shown in a number of different 
contexts. In early embryogenesis, before E16.5, -catenin expression in fibroblasts is required for the 
formation of the dorsal and ventral dermis, while ectopic -catenin activation increases fibroblast 
density and disturbs epidermal morphogenesis (Atit et al., 2006; Chen et al., 2012; Ohtola et al., 
2008). In late embryonic dermis, when fibroblast lineages have been established, altered -catenin 
activity in the DP causes defects in HF growth, cycling, and pigmentation but does not cause HF loss 
(Enshell-Seijffers et al., 2010a; 2010b). In contrast, -catenin activation in postnatal ventral dermis 
D
ev
el
o
pm
en
t •
 A
dv
an
ce
 a
rt
ic
le
 fibroblasts causes fibrosis in the adipocyte layer (Mastrogiannaki et al., 2016; Hamburg and Atit, 
2012; Hamburg-Shields et al., 2015), supporting our observations in older unwounded skin (Fig.7B).  
This corroborates the idea that -catenin activity can occur simultaneously in different fibroblast 
lineages performing distinct functions. Interestingly, during wound repair ectopic -catenin 
activation throughout the skin leads to increased wound size, fibroblast proliferation and fibrosis, 
while -catenin deletion decreases proliferation and wound size (Fig.9D,E; Beyer et al., 2012; Cheon 
et al., 2006).  
It is interesting that the postnatal mice growth does not correlate with an increase in fibroblast 
proliferation within the dermis (Collins et al., 2011; Collins et al., 2012) and our clonal analysis is 
consistent with a model whereby fibroblasts within a clone become separated from one another 
through ECM deposition. Fibroblast -catenin activation can stimulate ECM production (Hamburg-
Shields et al., 2015) but while this could play a role in dermal wound repair, it is unlikely to be the 
major mediator of postnatal dermal expansion, since signalling is downregulated postnatally.  
We conclude that postnatal dermal maturation facilitates rapid wound repair through recruitment of 
lower dermal fibroblasts but this comes at the expense of the skin to regenerate HF at the wound 
site. 
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 Figures 
 
Figure 1:  Wound-induced new HF formation (WINH) occurs in neonatal back and tail skin. (A) 
Histological analysis of 2mm wounds performed in PDGFRaH2BeGFP mice at postnatal ages by 
immunostaining for GFP (green) and Itga6 (red). White arrowheads indicate HF within the wound 
bed and white lines the wound edges.  (B) New follicles quantitation per wound bed section at PW7 
(n=4 biological replicates (P2,P21) or n=3 (other time points)). (C) Analysis of different HF 
morphogenesis stages during WINH in P2 wounds at PW7. Wound beds were immunostained for 
GFP (green) and Itga6 (red) or Lef1 (green) alone. (D) WINH in tail wounds. Tail wound beds were 
stained for Krt-17 (green) and Itga6 (red) and quantified (see Table S1). White arrowhead indicates 
new HF. (E-H) Light micrographs and quantification of PW7 wound area in back (E,F) and tail (G,H) 
skin wounds made at ages shown. (I) Wound area over time in neonatal and adult wounds as a 
surrogate for wound closure (n=6 biological replicates). (J-L) Lineage tracing strategy (J), histological 
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 analysis of tdtomato+ fibroblasts (red) labelled with Lrig1CreER and Dlk1CreER (K), and quantitation 
(L) in PW7 wound beds from P2 wounded mice. In (K) dotted lines denote epidermal-dermal 
boundary, white arrowhead indicates developing DP and white asterisk shows Lrig1CreER labelled 
keratinocytes (Page et al., 2013). (L) shows % of new HF with attached tdtomato+ fibroblasts (8 
wound bed sections per mouse; n=4 (Lrig1CreER), n=3 (DLK1CreER)). Nuclei are stained with DAPI 
(blue) in (A,C,D,K). Scale bars, 100µm (A,D), 50µm (C,K), 50mm (E,G). IP, intraperitoneal injection. 
Data shown are means±s.d. ns, not significant; *P<0.05; **P<0.005; ***P<0.0005. 
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Figure 2: Comparative gene expression analysis. (A) Comparison of genes that are differentially 
expressed between P1 back and tail dermis (Location) and between P2 and P50 dorsal fibroblasts 
(Time).  Representative GO term analysis of upregulated entities is shown. (B) Heatmap depicting 
the differentially expressed Wnt target genes among the four samples analysed.  
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Figure 3:  Changes in fibroblast density, marker expression, proliferation and apoptosis in 
postnatal back skin. (A-D) Fibroblast density and marker expression analysis. Immunostaining for 
Itga6 (A) and CD26, Lrig1, Dlk1 and Sca1 (red) (B) in PDGFRaH2BeGFP (green) skin. White dotted lines 
mark dermis layer boundaries in (A). (C) Mean dermal area between adjacent HF (right y-axis) and 
total fibroblast density per mm2 of dermis (left y-axis) over time (n=3 biological replicates per time 
point). (D) Fibroblast density in dermis layers indicated in (A) (n=3 biological replicates per time 
point). (E, F) Ki67 staining (red) of whole mounts (E) and quantification (F) of % Ki67+ 
PDGFRaH2BeGFP cells (green) (n=3 biological replicates per time point). (G,H) Cleaved Caspase-3 
(cCasp3) staining (red) of whole mounts (G) and quantification (H) of % cCasp3+ PDGFRaH2BeGFP 
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 cells (green) (n=3 biological replicates per time point). Note that most apoptotic cells in the skin are 
observed in the IFE and HF keratinocytes (white arrowheads in G). Nuclei were labelled with DAPI 
(A,B,E,G). Pap, papillary dermis; Ret, reticular dermis; DWAT, dermal white adipose tissue. Scale bars 
100µm. Data shown are means±s.d. **P<0.005; ***P<0.0005. 
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Figure 4: Estimation of cellular replication during dermal maturation and clonal analysis of 
PDGFRaCreERt2 positive cells. (A) Predicted number of dermal fibroblast divisions (trunk skin) 
during the transition from neonatal (P2) to adult (P50) mouse. Height, length and dermis diameter 
were measured (n=3 mice per time point and gender) and the dermis volume was estimated by 
representing the mouse trunk as a cylinder. Cell densities were obtained from Fig.3C and the cell 
number at P2 (N0) and P50 (N) were estimated by multiplying cell density and dermis volume. The 
predicted cell division rate (n=1.3) is calculated by the log2 of the N/N0 ratio. All raw data for the 
calculations are shown in Table S3. (B-H) Clonal analysis of PDGFRaCreERt2+ cells. (B) Breeding 
strategy for (E-H). (C) Labelling strategy for (E,F). (D) Labelling strategy for (G,H). (E) Immunostaining 
of GFP labelled fibroblasts (green) co-stained for Dlk1 or Itga8 (red) or overlaid with brightfield 
image. (F) Quantitation of GFP+ cells per clone per compartment (n=3 biological replicates per time 
point). Cells were considered clonally related if they were contained within a total dermal area of 
260m diameter (Driskell et al., 2013). (G) Immunostaining of GFP+ fibroblasts.  (H) Quantitation of 
GFP+ fibroblasts in the area between adjacent HF (n=3 biological replicates per time point). Nuclei 
were labelled with DAPI (E,G). IFE, Interfollicular epidermis; Ret, reticular dermis; DP, dermal papilla; 
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 Pap, papillary dermis; DWAT, dermal white adipose tissue; E, embryonic; P, postnatal. Scale bars, 
1cm (A), 100µm (E middle and right panel, G) and 500µm (E left panel). Data shown are means±s.d.  
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Figure 5: Dermal Wnt signalling activity.  (A,B) Immunostaining for TOPGFP signal (green) and the 
markers indicated (CD26 (red) and Sca1 (blue) in A; Lef1, TCF1, TCF4, DKK1 and CyclinD1 (red) in B). 
Nuclei were labelled with DAPI (white in A, blue in B). (C) Quantitation of % TOPGFP+ dermal 
fibroblasts determined from histological sections (n=3 biological replicates per time point) (D,E) Flow 
cytometry analysis of TOPGFP expression in P2 fibroblast subpopulations. Gate1: CD26+Sca1- 
(papillary fibroblasts); gate2: Dlk1+Sca1- (reticular fibroblasts); gate3: Dlk1+Sca1+ and gate4: Dlk1-
Sca1+ (cells with adipogenic potential). (C) is representative of n=3 biological replicates shown in (D). 
Scale bars, 50µm (A,B). Data shown are means±s.d. *P<0.05; ***P<0.0005.  
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Figure 6:  Analysis of neonatal and adult wound beds. (A,B) TOPGFP expression in fibroblasts of 
PW5, PW7 and PW10 wound beds of mice wounded at neonatal (P2) and adult (P21 and P50) age. 
Wound beds were immunostained for GFP (green), Lrig1 (red) and Sca1 (blue) (A). TOPGFP 
expression in boxed areas in (A) is shown at higher magnification below each image Placodes are 
marked with white asterisks and dotted lines indicate basement membrane. (B) Quantitation of 
GFP+ cells in wound beds at indicated time points (n=4 biological replicates (P2); n=3 (P21, P50) at 
PW7; n=4 all other time points). (C) Dermal cells per mm2 wound bed area over time in adult and 
neonatal wounds (n=4 biological replicates). (D,E) Mean immunofluorescence quantification in the 
neonatal (P2) and adult (P21 and P50) wound beds over time for Lrig1 (D) and Sca1 (E) (n=4 
biological replicates per time point) (F) DKK1 expression (red) in TOPGFP (green) P2 and P50 wound 
beds at PW7. (G,H) PW7 wound beds wounded at indicated time point immunostained for Itga8 
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 (green) (G) and αsma (green) (H). (I) Quantitation of the density of PDGFRaH2BeGFP expressing cells 
in PW7 wound beds wounded at indicated time points (n=3 biological replicates per time point). 
(J)Quantitation of Ki67+ cells in the wound beds wounded at indicated time points (n=8 (P2), 6 (P4), 
4 (P21), 5 (P50) biological replicates). Nuclei were labelled with DAPI (A in white; F-H in blue). Scale 
bars, 100µm. Data shown are means±s.d. ns, not significant; *P<0.05; ***P<0.0005. 
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Figure 7: Effect of postnatal dermal β-catenin ablation or activation on skin homeostasis. (A,B) 
Immunostaining of Lrig1 (green, top panel), CD26 (green, lower panel) and Sca1 (red) in neonatal 
(P10) and adult (P57) whole mount sections of wild type mice (Control) or following β-catenin 
ablation (Ctnnb1(KO)) or activation (Ctnnb1(Ex3), as shown in Fig.9A. White dotted lines indicate 
dermis layer boundaries. (C,D) Quantification of cell densities in indicated dermis layer in (A,B) in 
neonatal  (P10) (C) and adult (P57) (D) whole mount sections.  (n=6 whole mount sections per 
mouse, 3 biological replicates per genotype and time point). (E) Quantification of dermal thickness at 
indicated time points (n=5 biological replicates per genotype and time point). Nuclei were labelled 
with DAPI (blue). Scale bars, 100µm. Data shown are means±s.d.  
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Figure 8: TOPGFP activity and -catenin deletion efficiency in dermal fibroblasts. (A) TOPGFP 
activity (green) with Lrig1 immunostaining (red) in P21 wounds at PW7 of wild type (Control) and β-
catenin deleted (Ctnnb1(KO)) mice. (B) Quantitation of GFP+ cells in PW7 wound beds (n=6 whole 
mount sections per mouse; 4 (Control), 2 Ctnnb1(KO) biological replicates). (C) Schematic 
representation of undeleted and deleted targeted allele for -catenin deletion with arrows 
indicating the amplified region of DNA in the PCR between primer pairs (left panel). DNA from sorted 
tdtomato positive (+) and negative (-) cells was tested for Ctnnb1 deletion. This allows amplification 
of a 480bp band (Ctnnb1 deletion PCR) and loss of the 180bp product (loxP PCR), while undeleted 
cells (tdtomato-) generate no band (Ctnnb1 deletion PCR) and a 180bp band (loxP PCR). Note that in 
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 heterozygous mice (Ctnnb1(Het)) the untargeted allele amplifies as a 150bp band due to the missing 
loxP site. Rpl19 PCR was used as loading control. (D) TOPGFP activity (green) with Lrig1 
immunostaining (red) in P8 wounds at PW7 of wild type (Control) and β-catenin stabilized 
(Ctnnb1(Ex3)) mice.  (E) Quantitation of GFP+ cells in PW7 wound beds (n= 6 whole mount sections 
per mouse; 4 biological replicates per genotype). (F) Schematic representation of wild type, 
undeleted and deleted targeted Exon3 allele for β-catenin stabilization with arrows indicating the 
amplified region of DNA in the PCR between primer pairs (left panel). DNA isolated from whole 
mount sections was tested for -catenin Exon3 deletion. Wild type allele amplifies as a 900bp band, 
undeleted targeted allele gives no product and deleted targeted allele amplifies as a 700bp band. 
Note that Ctnnb1(Ex3) transgenic is kept heterozygote, thus PCR shows efficient recombination. NC, 
negative control; bp, base pairs.  (A,D) Nuclei were labelled with DAPI (blue) and white arrowheads 
indicate new HF. Scale bars, 100µm.  
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Figure 9: Effect of β-catenin ablation or activation on HF formation in wound beds.  (A) 
Experimental design. (B,C) Immunostaining  analysis (B) and quantification (C) for Lrig1 (green) and 
Sca1 (red) in PW7 wound beds of wild type mice (Control) or following β-catenin ablation 
(Ctnnb1(KO)) or activation (Ctnnb1(Ex3)) wounded at P4 (n=3 whole mount sections per mouse; 5 
biological replicates per genotype). (D-F) Quantification of Ki67+ cells in the wound bed area (D), 
dermal cells in the wound bed (E) and wound bed area (F) at PW7 of  wild type mice (Control) or 
following β-catenin ablation (Ctnnb1(KO)) or activation (Ctnnb1(Ex3)) wounded at indicated time 
points (for (D) n=5 (P50 Control, Ctnnb1(KO)), 7 (P4 Control), 4 (P4 Ctnnb1(KO), Ctnnb1 (Ex3), P50 
Ctnnb1(Ex3)); for (E) n=5 biological replicates; for (F) n=6). (G,I) Immunostaining of new HF in PW7 
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 wound beds of mice following β-catenin ablation (G) or activation (I) in postnatal fibroblasts. Wound 
beds were immunostained for Krt-14 (red), Itga6 (green) or tdtomato (red) as indicated. White lines 
indicate wound edges, white arrowheads new HF and arrow enlarged new HF. (H,J) Quantitation of 
HF formation in wound beds (G,I) (for (H) n=8 (P4 Control, P50 Ctnnb1(KO)), 6 (P4 Ctnnb1(KO)) or 9 
(P50 Control) ; for (J) n=9 (P4 Control), 4 (P4 Ctnnb1(Ex3), P50 Control, Ctnnb1(Ex3)) or 3 (P21 
Control, Ctnnb1(Ex3)) biological replicates). Nuclei were labelled with DAPI (blue) in (B,G,I). Scale 
bars, 100µm. Data shown are means±s.d. ns, not significant; *P<0.05; **P<0.005; ***P<0.0005; IP, 
intraperitoneal injection. 
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